- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02175082
Cycling in Parkinson's Disease
October 19, 2020 updated by: Christina Marciniak, Shirley Ryan AbilityLab
A Forced Cycling Exercise Program in Individuals With Parkinson's Disease: Can it Improve Gait Parameters?
The purpose of this study is to assess the effectiveness of a forced exercise aerobic exercise program, utilizing a cycling activity, on specific gait parameters and balance in individuals with Parkinson's Disease (PD).
Design: pilot, feasibility, randomized control, evaluator blinded.
Subjects: Twenty four patients with idiopathic PD Hoehn and Yahr (H&Y) stage II or III.
Intervention: Participants randomly assigned to one of two exercise groups, forced exercise or self selected exercise, on cycling machine three times a week for 8 weeks.
Both groups to exercise at same aerobic intensity level to keep heart rate at 60-80% heart rate max.
Outcomes: Gait parameters of step length, width, and variability as measured by the GAITRite; 6 Minute Walk Test; mini-BESTest (balance testing); exercise tolerance via Patient Reported Outcomes Measurement Information System (PROMIS) scale.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Idiopathic Parkinson's Disease
- Hoehn and Yahr Stages II - III.
- Ages 30-80 years
- Medical Clearance
- Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
- MOCA: (Montreal Cognition Scale) : rating of less than 24, indicative of cognitive dysfunction
- Changes in Parkinson's medications within the two weeks prior to starting the study
- Anticipated change in Parkinson Disease medications during the course of the study
- Uncontrolled orthostasis
- Symptomatic coronary artery disease
- Fracture of lower limb within 6 months prior to study onset or significant lower limb orthopedic diagnosis that would limit cycling
- Other significant neurologic diagnoses including multiple sclerosis or vestibular disease
- Acute illness
- Physical therapy within the month prior to study entry
- Subjects already participating in a forced exercise or high intensity exercise program
- Any medical condition that the physician investigator determined would compromise safety.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Forced exercise cycling
Cycling exercise at approximately 90 rpm
|
|
|
Active Comparator: Self-selected pace cycling
Cycling at self selected rate, with same aerobic level as forced cycling group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-minute walk test
Time Frame: 8 weeks
|
Distance walked in 6 minutes
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stride length
Time Frame: 8 weeks
|
Length of stride in meters as measured by the GAITrite
|
8 weeks
|
|
Step Width
Time Frame: 8 weeks
|
Width of step in meters as measured by the GAITrite
|
8 weeks
|
|
Step variability
Time Frame: 8 weeks
|
Standard deviation of step as measure in meters by the Gaitrite system
|
8 weeks
|
|
10 meter walk test
Time Frame: 8 weeks
|
Time in seconds for the subject to walk 10 meters
|
8 weeks
|
|
miniBESTest (Balance Evaluation Systems Test)
Time Frame: 8 weeks
|
Subject is scored as the 14 activities on this scale are performed, and a summary score is derived.
|
8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Steps per day
Time Frame: Over 8 week trial and for 2 months post intervention
|
Subjects steps per day will be measured with a Garmin wrist step counter
|
Over 8 week trial and for 2 months post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christina M Marciniak, MD, Shirley Ryan AbilityLab/Northwestern University Chicago IL
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sung P, Rafferty M, Doyle L, Kliver E, Bines K, Traines J, Scarpa A, Marciniak C, Solanki S, Todd A. Technology-based Forced Paced Cycling in Parkinson's disease: Is it Feasible and Effective?Archives of PM&R October 2019Volume 100, Issue 10, Page e126
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2014
Primary Completion (Actual)
June 1, 2019
Study Completion (Actual)
June 1, 2019
Study Registration Dates
First Submitted
June 21, 2014
First Submitted That Met QC Criteria
June 24, 2014
First Posted (Estimate)
June 26, 2014
Study Record Updates
Last Update Posted (Actual)
October 22, 2020
Last Update Submitted That Met QC Criteria
October 19, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00093757
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
EicOsis Human Health Inc.University of California, Davis; Michael J. Fox Foundation for Parkinson's...RecruitingParkinson's Disease (PD)United States
-
University of Kansas Medical CenterNot yet recruitingParkinson's Disease (PD)United States
-
AbbVieRecruiting
-
University Hospital Schleswig-HolsteinUniversity of Kiel; University of Cologne; University Hospital, Bonn; Philipps...Not yet recruitingParkinson's Disease (PD)
-
InvicroMerck Sharp & Dohme LLCRecruitingParkinson's Disease | Parkinson's Disease (PD) | Parkinson's Disease (Disorder)United States
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Guangzhou Henovcom Bioscience Co. Ltd.Frontage Clinical Services, Inc.Active, not recruitingParkinson's Disease (PD)United States
-
Universitätsklinikum Hamburg-EppendorfUniversity of TwenteRecruitingParkinson's Disease | Deep Brain StimulationGermany
-
Mission TherapeuticsMichael J. Fox Foundation for Parkinson's Research; Parkinson's UKRecruitingParkinson's Disease (PD) | Early Stage Parkinson's Disease | Mild to Moderate Parkinson's DiseaseUnited Kingdom
Clinical Trials on Cycling at Forced rate
-
VA Office of Research and DevelopmentRecruitingParkinson's DiseaseUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
The University of Texas Health Science Center,...TerminatedHypothermia; Anesthesia | Hypothermia, Newborn | Hypothermia, SequelaUnited States
-
Chulalongkorn UniversityCompletedAllergic RhinitisThailand
-
Kahramanmaras Sutcu Imam UniversityCompletedAerobic Capacity | Blood Flow Restriction Exercise | Isokinetic | VO2max | Muscle Strengh | Blood Flow Restriction (BFR) Training EffectsTurkey
-
MedtronicNeuroCompleted
-
EgymedicalpediaRecruitingPCOS (Polycystic Ovary Syndrome) of Bilateral OvariesEgypt
-
Federico II UniversityUnknownHeart Failure | Exercise ToleranceItaly
-
University of Western Ontario, CanadaMirexus Biotechnologies IncUnknown
-
Virginia Commonwealth UniversityTerminatedNon-small Cell Lung Cancer | Recurrent Non-Small Cell Lung CarcinomaUnited States